NEW YORK,
Nov. 14,
2023 /PRNewswire/ -- The Gross Law Firm issues the
following notice to shareholders of Brainstorm Cell
Therapeutics Inc..
Shareholders who purchased shares of BCLI during
the class period listed are encouraged to contact the firm
regarding possible lead plaintiff appointment. Appointment as lead
plaintiff is not required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/brainstorm-cell-loss-submission-form/?id=55625&from=4
CLASS PERIOD: August 15, 2022 to September 27, 2023
ALLEGATIONS: The complaint
alleges that during the class period, Defendants
issued materially false and/or misleading statements and/or failed
to disclose that: (1) Brainstorm Cell downplayed the severity of
the refusal to file letter it received from the U.S. Food and Drug
Administration regarding NurOwn ; (2) Brainstorm Cell
continued to conceal the risks associated with the submission of
the Biologics License Application for NurOwn; and (3) as a result,
defendants' statements about its business, operations, and
prospects, were materially false and misleading and/or lacked a
reasonable basis at all relevant times.
DEADLINE: January 2,
2024 Shareholders should not delay in registering for
this class action. Register your information here:
https://securitiesclasslaw.com/securities/brainstorm-cell-loss-submission-form/?id=55625&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you
register as a shareholder who purchased shares of BCLI during the
timeframe listed above, you will be enrolled in a portfolio
monitoring software to provide you with status updates throughout
the lifecycle of the case. The deadline to seek to be a lead
plaintiff is January 2, 2024. There
is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is
a nationally recognized class action law firm, and our mission is
to protect the rights of all investors who have suffered as a
result of deceit, fraud, and illegal business
practices. The Gross Law Firm is committed to ensuring that
companies adhere to responsible business practices and engage in
good corporate citizenship. The firm seeks recovery on behalf of
investors who incurred losses when false and/or misleading
statements or the omission of material information by a company
lead to artificial inflation of the company's stock. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original
content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-brainstorm-cell-therapeutics-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-january-2-2024--nasdaq-bcli-301986815.html
SOURCE Gross Law Firm